Table 3.
Most promising gut isolates showing antagonistic activity against indicators of choice.
| Strain Designation | Media | Indicator | Taxonomy Method | Genus/Species | Method of Bacteriocin Prediction | Bacteriocin Predicted | AMR Genes Identified |
|---|---|---|---|---|---|---|---|
| LW001 | mMRS × 2 [Mupirocin] | Listeria innocua | 16s rRNA | Enterococcus | MALDI-TOF | Enterocin Q | n/a |
| LW002 | mMRS × 2 [Mupirocin] | Listeria innocua | 16s rRNA | Enterococcus | MALDI-TOF | Enterocin Q | n/a |
| LW003 | mMRS × 2 [Mupirocin] | Lactobacillus bulgaricus | 16s rRNA | Enterococcus | MALDI-TOF | Enterocin 62-6 | n/a |
| DPC7281 | WCA | Fusobacterium nucleatum | WGS |
Enterococcus
faecalis |
WGS + BAGEL4 | Enterolysin A |
dfrE, efrA, tetM, ermB, E. faecalis chloramphenicol acetyltransferase, aad(6), SAT-4, APH(3′)-IIIa |
| DPC7280 | WCA | Fusobacterium nucleatum | WGS |
Enterococcus
faecalis |
WGS + BAGEL4 | Enterolysin A Enterocin NKR-5-3B Sactipeptide |
dfrE, efrA |
| DPC7282 | WCA | Clostridioides difficile | WGS |
Enterococcus
mundtii |
WGS + BAGEL4 | Enterocin CRL35 | No AMR genes identified |